Vintage Coffee and Beverages (538920) Q4 12/13 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 12/13 earnings summary
28 Oct, 2026Executive summary
FY ended Mar. 31, 2013 income was Rs. 15,000; net loss widened to Rs. 28,984 from Rs. 12,649 in FY12. No dividend was recommended due to losses.
Directors cited efforts to improve performance; AGM remarks highlighted substantial working-capital and growth funding needs.
Financial highlights
Total income was Rs. 15,000 vs. nil in FY12; expenditure rose to Rs. 43,984 from Rs. 12,649, resulting in a Rs. 28,984 loss before tax.
Paid-up share capital remained Rs. 1,247,000; accumulated losses reached Rs. 1,820,983 at Mar. 31, 2013, compared with Rs. 1,791,999 a year earlier.
No income-tax provision was recorded as the year ended in a loss; no dividend was recommended.
Outlook and guidance
Directors said they were working to improve performance; AGM remarks identified substantial funding needs for working capital and growth-related activities.
The chairman explained the rationale for a proposed warrant issue to a strategic investor; the available minutes do not record an outcome for that proposal.
Latest events from Vintage Coffee and Beverages
- Volume-led growth, positive cash flow and freeze-dried expansion drive momentum.538920
Q2 26/27 - FY14 returned to profit, as board renewal advanced a revival plan amid suspended share trading.538920
Q4 13/14 - No operating income, continued losses and material audit uncertainty marked FY2011/12.538920
Q4 11/12 - Revenue and earnings fell sharply; future growth plans face macro and going-concern risks.538920
Q4 14/15 - A control-changing share swap shifted the business toward coffee and chicory exports.538920
Q4 20/21 - FY16 PAT dropped to ₹494; no dividend, with diversification planned.538920
Q4 15/16 - FY17 income rose to ₹8.23m; management retained profits and eyed diversification.538920
Q4 16/17 - Income and profit fell sharply; profits were retained as management planned diversification.538920
Q4 17/18 - FY19 revenue contracted sharply, but PAT rose as management pursued rehabilitation options.538920
Q4 18/19